Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer.
about
Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI)A Review of Systemic Treatment in Metastatic Triple-Negative Breast CancerAre there efficacious treatments for treating the fatigue-sleep disturbance-depression symptom cluster in breast cancer patients? A Rapid Evidence Assessment of the Literature (REAL(©))Nanocarriers for diagnosis and targeting of breast cancerPancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment.Breast cancer (metastatic).Chemotherapy with low-dose capecitabine as palliative treatment in a patient with metastatic breast cancer: a case report.Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model.Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel mA cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in TurkeyTemporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer.PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review.Symptom control.Combination drug delivery approaches in metastatic breast cancerHealth state utilities for metastatic breast cancer.Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcomePalliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.Long-term course of pain in breast cancer survivors: a 4-year longitudinal study.Sequential Metastatic Breast Cancer Chemotherapy: Should the Median be the Message?Quality of life assessments in advanced breast cancer: should there be more consistency?Cancer-related insomnia.Evaluating the role of nab-paclitaxel (Abraxane) in women with aggressive metastatic breast cancer.Does palliative chemotherapy provide a palliative effect on symptoms in late palliative stages? An interview study with oncologists.Usefulness of palliative prognostic score in the treatment of patients with non-resectable gastric cancer.Treatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma.Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients.Specific anticancer treatments in the last 3 months of life: a French experience.What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN).Adhesion, proliferation, and apoptosis in different molecular portraits of breast cancer treated with silver nanoparticles and its pathway-network analysis.Metastatic breast cancer: do current treatments improve quality of life? A prospective study.Practical consensus recommendations on management of triple-negative metastatic breast cancer.Breast cancer (metastatic)Palliative Care for Children with Advanced Cancer
P2860
Q24801760-50D5B07C-06B4-4E7E-957A-B5DDE487BFB0Q26752846-92471F6A-C779-4C10-BEC5-9474093D181EQ26785468-C455FD26-0AF0-43D7-AC9F-5D9CB7D68CE2Q26862309-8751BA3C-C678-47D8-B410-88F697E78502Q30725747-374A8B04-BCD8-413D-A45B-3EE3C030F190Q33448016-DBA8B9D7-CFDD-4842-8916-14D9F51FF9E0Q33580239-8C4BECCD-710A-45F4-A0A3-988AEB6D902FQ33790374-5DE6B703-96FE-4162-B316-A5051977ED7CQ34020507-4A1BBD4C-048C-45F9-9612-424ED70CFA09Q34130479-82B20267-C007-4D7A-B318-9D48CB5312EFQ34961213-CFC38CDD-6839-48DE-988C-DBE992F842D2Q34982384-7639CD6E-D0B9-4775-8611-ED0CD9A059D0Q35205290-E7EC05FA-55B8-4B50-A3AA-5A0D3DC61845Q35553856-2FB1B31E-CA3A-4B92-B13E-4E6940BFDE81Q35955198-3E7056C2-18A0-412F-A750-E5D25983CF19Q36591214-4CFE0FF4-2C05-4B69-932F-44160D3CB07EQ36623000-EDCF6218-C6ED-48E4-9138-B47163584E84Q36670778-8FFD2448-1984-47D1-B9F1-A4FD511B887DQ36673526-1D279758-5823-41DF-9711-694C8F8850C5Q36926251-C4D2E7A8-81DF-46A0-856E-8EF0DA04EF3FQ37385471-E5127136-8021-4116-854B-4303D98CD189Q38016575-B9DD051E-3B43-4BC7-B4E2-7A8C11D3EF02Q38154218-850E9161-6794-4D9A-9EF3-2726349579F9Q39243591-4EB9F962-9271-4155-B66D-29CB9FE9DB74Q40054127-5FBA5D3A-95B0-49FC-AA43-3931DD941873Q41833974-87032AF8-BCFE-4BE2-B132-7266882FEE17Q42427607-AC3E281A-5E9F-4988-9E9C-EF298E73BA55Q43824330-10CDEA3F-7074-4E81-997D-3D2D5906142DQ44017247-CE25FE5F-CCA2-474A-9A2F-0FC4F6FC6CF3Q48177429-9B3B0C3B-C0FE-48FE-B642-34FCBF86775CQ51744595-5950CBC1-173E-4F94-89E5-010A453B2BE5Q51910459-E3F3CEB7-7EF4-49AB-8A6D-3A70D360C5B7Q55120303-49704CA5-D614-482A-8BB6-C69D80F0FA34Q57139202-BF36855C-15BF-4DCF-8FBA-AA4DE67AF2F3Q57821785-34573D71-B67D-466C-9A07-B4700934D656
P2860
Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Palliative effect of chemother ...... with metastatic breast cancer.
@ast
Palliative effect of chemother ...... with metastatic breast cancer.
@en
type
label
Palliative effect of chemother ...... with metastatic breast cancer.
@ast
Palliative effect of chemother ...... with metastatic breast cancer.
@en
prefLabel
Palliative effect of chemother ...... with metastatic breast cancer.
@ast
Palliative effect of chemother ...... with metastatic breast cancer.
@en
P2093
P1476
Palliative effect of chemother ...... with metastatic breast cancer.
@en
P2093
P304
P356
10.1200/JCO.2000.18.12.2395
P407
P577
2000-06-01T00:00:00Z